scriba-nanotec.com
About company
Founded in 2005 as a spin-off of the National Council of Research (CNR) , Scriba Nanotecnologie involves in its corporate team the two founders, Prof. Fabio Biscarini and Dr. Massimiliano Cavallini. In 2008 IMA SpA, a leading industrial group in packaging machines for pharma, tea and coffee, joined Scriba as industrial partner. As a highly innovative SME, Scriba Nanotechnologie has been active partner in nine research projects at European level, funded by FP6 programs, FP7 and H2020. Scriba Nanotecnologie is committed to the safeguarding of human and enviroment health. For this reason has developed an innovative system for capillary controlling of the cold chain of medicinal products and consumables: the TTAG, a project funded in Phase 1 by the EU in 2016.
